2006
DOI: 10.1016/j.yjmcc.2006.01.015
|View full text |Cite
|
Sign up to set email alerts
|

Sustained augmentation of cardiac α1A-adrenergic drive results in pathological remodeling with contractile dysfunction, progressive fibrosis and reactivation of matricellular protein genes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
37
0
1

Year Published

2006
2006
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(42 citation statements)
references
References 49 publications
4
37
0
1
Order By: Relevance
“…To clarify this, we testified the PE effect on [Ca 2+ ] i in freshly isolated and cultured NRVM for <1 day and ≥2 day for compatibility with the aortic myocytes. As expected, all of the cardiomyocytes from either group [20,24,[31][32][33] . Similar to other studies [9,13,14,24,32] , we combined selective antagonists for each subtype with selective agonists to distinguish among contributions of the different subtypes to vasoconstriction.…”
Section: Ar Activationsupporting
confidence: 70%
See 1 more Smart Citation
“…To clarify this, we testified the PE effect on [Ca 2+ ] i in freshly isolated and cultured NRVM for <1 day and ≥2 day for compatibility with the aortic myocytes. As expected, all of the cardiomyocytes from either group [20,24,[31][32][33] . Similar to other studies [9,13,14,24,32] , we combined selective antagonists for each subtype with selective agonists to distinguish among contributions of the different subtypes to vasoconstriction.…”
Section: Ar Activationsupporting
confidence: 70%
“…However, unlike the situation for α 1A -and α 1B -ARs, information regarding α 1D -AR cellular functions and their underlying regulatory mechanisms is scant because of the difficulties in obtaining sufficient function in native or recombinant cells in vitro, raising the question of whether manifestations of the α 1D -ARs expressed in vitro are, in fact, representative of the physiological situation [9,11,12] . In the current study, we sought to determine the causes for the inconsistencies in α 1 AR regulatory effects on vascular contractility between the in vivo and in vitro studies by comparing α 1 AR-mediated Ca 2+ signaling and its subcellular distribution in native rat aortic and cardiac myocytes (α 1D -AR and α 1A -AR subtypes are known to contribute mainly to α 1 adrenergic mediation of constriction in the rat aorta [13,14] and cardiac muscle [20][21][22][23][24] , respectively).…”
Section: Introductionmentioning
confidence: 99%
“…Cardiac myocyte-specific transgenic overexpression of the WT a 1 A-subtype, even at very high levels (148-to 170-fold), does not alter heart size, although a 1 A transgenic mice eventually develop dilated cardiomyopathy and die prematurely (Lin et al, 2001;Chaulet et al, 2006). On the other hand, transgenic overexpression of constitutively active mutant (CAM) a 1 A with the endogenous a 1 A-promoter induces cardiac hypertrophy without an effect on systemic blood pressure (Papay et al, 2013).…”
Section: A a 1 -Adrenergic Receptors Activate Physiologic Or Adaptivmentioning
confidence: 99%
“…Hence, the grade of occlusion in IRA should be shown in all of the patients with acute coronary syndromes. The expression of tenascin-C increases the early phase of fibrosis and cardiac repair after cardiac injury 20) . It has also been observed in human coronary atherosclerotic plaque 7) but the relation between higher tenascin-C levels and the coronary lesion's anatomy was indeterminate.…”
Section: Discussionmentioning
confidence: 99%